The ENHANCE study and marketing ezetimibe - Reply

Philip Greenland; Donald M Lloyd-Jones

doi:10.1001/jama.299.23.2747-b

The ENHANCE study and marketing ezetimibe - Reply

Philip Greenland^*, Donald M Lloyd-Jones

^*Corresponding author for this work

Preventive Medicine

Research output: Contribution to journal › Letter › peer-review

Original language	English (US)
Pages (from-to)	2747-2748
Number of pages	2
Journal	JAMA - Journal of the American Medical Association
Volume	299
Issue number	23
DOIs	https://doi.org/10.1001/jama.299.23.2747-b
State	Published - Jun 18 2008

ASJC Scopus subject areas

General Medicine

Access to Document

10.1001/jama.299.23.2747-b

Cite this

@article{b81cd9912e9d4a548754486d3cd8e3f9,

title = "The ENHANCE study and marketing ezetimibe - Reply",

author = "Philip Greenland and Lloyd-Jones, {Donald M}",

year = "2008",

month = jun,

day = "18",

doi = "10.1001/jama.299.23.2747-b",

language = "English (US)",

volume = "299",

pages = "2747--2748",

journal = "JAMA - Journal of the American Medical Association",

issn = "0098-7484",

publisher = "American Medical Association",

number = "23",

}

TY - JOUR

T1 - The ENHANCE study and marketing ezetimibe - Reply

AU - Greenland, Philip

AU - Lloyd-Jones, Donald M

PY - 2008/6/18

Y1 - 2008/6/18

UR - http://www.scopus.com/inward/record.url?scp=45349086649&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=45349086649&partnerID=8YFLogxK

U2 - 10.1001/jama.299.23.2747-b

DO - 10.1001/jama.299.23.2747-b

M3 - Letter

C2 - 18560001

AN - SCOPUS:45349086649

SN - 0098-7484

VL - 299

SP - 2747

EP - 2748

JO - JAMA - Journal of the American Medical Association

JF - JAMA - Journal of the American Medical Association

IS - 23

ER -

The ENHANCE study and marketing ezetimibe - Reply

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this